Tag Archives: Supreme Court

Patents at the Supreme Court: Update and Fallout

Posted on August 26, 2013 by Warren Woessner

Warren Woessner and Charles R. Macedo will speak on patentable subject matter post-Myriad, Prometheus and CLS in the upcoming AUTM Webinar on September 12. Warren (Schwegman Lundberg) will present on the patentability of life sciences’ inventions such as diagnostics, drug … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged AUTM, Charles Macedo, Federal Circuit, Lee Heiman, Myriad, Prometheus, Supreme Court, Warren Woessner | Leave a comment

Myriad Brings Out Its “Reserve Claims” To Challenge Ambry

Posted on July 10, 2013 by Warren Woessner

In my post on this blog of June 17th, I speculated that the positive comments by the Supreme Court in the Myriad decision about the patent-eligibility of claims directed to new applications of natural products (like the BRCA genes) would … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Ambry, BRCA DNA, Judge Bryson, Myriad, Patent Law, Supreme Court | Leave a comment

Can AMP v. Myriad Revive Diagnostic Method Claims?

Posted on June 17, 2013 by Warren Woessner

At the end of the Supreme Court’s Opinion, Justice Thomas makes it clear that the Court was impressed by Judge Byson’s dissents in the Fed. Cir. Myriad opinions. Although Judge Bryson was on the Intema panel that sank claims to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged AMP v. Myriad, BRCA DNA, Federal Circuit, Patent Law, Supreme Court, Warren Woessner | 4 Comments

Association For Molecular Pathology V Myriad Genetics – An Isolated Local Difficulty?

Posted on June 14, 2013 by Warren Woessner

Paul Cole, Professor of Intellectual Property Law at Bournemouth University and European Patent Attorney at Lucas & Co, Warlingham, Surrey, UK discusses yesterdays Myriad ruling by the Supreme Court. How does yesterday’s Supreme Court decision match international opinion on the patentability … Continue reading →